As the serum concentrations of LRG1 are elevated in patients with various diseases, including cancer, diabetes, cardiovascular disease, and inflammatory disorders5, LRG1 has received attention as a prognostic/diagnostic biomarker in these diseases. This evidence concerns the gene LRG1 and cancer.